Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
95.21
+0.10 (0.11%)
At close: May 9, 2025, 4:00 PM
96.17
+0.96 (1.01%)
After-hours: May 9, 2025, 7:46 PM EDT
Zimmer Biomet Holdings Market Cap
Zimmer Biomet Holdings has a market cap or net worth of $18.84 billion as of May 9, 2025. Its market cap has decreased by -24.42% in one year.
Market Cap
18.84B
Enterprise Value
24.78B
1-Year Change
-24.42%
Ranking
Category
Stock Price
$95.21
Market Cap Chart
Since July 25, 2001, Zimmer Biomet Holdings's market cap has increased from $5.76B to $18.84B, an increase of 226.93%. That is a compound annual growth rate of 5.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 18.82B | -10.51% |
| Dec 31, 2024 | 21.03B | -17.32% |
| Dec 29, 2023 | 25.43B | -4.95% |
| Dec 30, 2022 | 26.76B | 0.82% |
| Dec 31, 2021 | 26.54B | -16.91% |
| Dec 31, 2020 | 31.94B | 3.74% |
| Dec 31, 2019 | 30.79B | 45.52% |
| Dec 31, 2018 | 21.16B | -13.41% |
| Dec 29, 2017 | 24.43B | 18.20% |
| Dec 30, 2016 | 20.67B | -1.12% |
| Dec 31, 2015 | 20.91B | 8.84% |
| Dec 31, 2014 | 19.21B | 20.55% |
| Dec 31, 2013 | 15.93B | 37.77% |
| Dec 31, 2012 | 11.57B | 20.83% |
| Dec 30, 2011 | 9.57B | -9.69% |
| Dec 31, 2010 | 10.60B | -15.81% |
| Dec 31, 2009 | 12.59B | 38.69% |
| Dec 31, 2008 | 9.08B | -41.54% |
| Dec 31, 2007 | 15.53B | -16.99% |
| Dec 29, 2006 | 18.71B | 11.94% |
| Dec 30, 2005 | 16.71B | -14.98% |
| Dec 31, 2004 | 19.65B | 15.44% |
| Dec 31, 2003 | 17.02B | 110.23% |
| Dec 31, 2002 | 8.10B | 36.81% |
| Dec 31, 2001 | 5.92B | 2.73% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.56B |
| Johnson & Johnson | 378.57B |
| UnitedHealth Group | 353.07B |
| AbbVie | 334.27B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.19B |
| Novartis AG | 220.92B |
| AstraZeneca | 217.30B |